MarginsXMarginsX
Home › Markets › ATXI

Avenue Therapeutics, Inc. (ATXI)

ATXI is quoted over the counter, not listed on an exchange. Avenue Therapeutics, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.2570
-8.2% on the day
1-year return
-66.2%
Market cap
$847K
Nano cap. From the Nov 16, 2026 close × 3.3M shares (10-Q cover page, Nov 4, 2026)
P/E and P/S
Net loss over the period · No revenue line filed
On trailing twelve months to September 30, 2026 (10-Q)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerATXI, quoted over the counter
SEC CIK0001644963
OTC Markets tierOTCID (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressBay Harbor Islands, FL
Incorporated inDE

Warning signs

Cash runway
8.3 months
$1.5M cash at September 30, 2026
Share count, 1 year
+3.5%
2025-11-12 to 2026-11-04 · +1765.4% over 3 years
Going-concern doubt
Yes
10-Q filed November 6, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors individually and collectively cause substantial doubt about the Company's ability to continue as a going concern to exist within one year from the date of this report."
10-Q 2026-11-06
Cash and burn$1.5M cash; operating cash flow -$547K a quarter.Report 2026-09-30
Shares outstanding3,294,967 (2026-11-04); 3,183,558 a year earlier; 13,247,622 three years earlier. 3y figure adjusted for splits (1-for-75 overall).Cover page 2026-11-04
Reverse splits, 3 years1; latest 1-for-75 on 2024-04-26Source 2024-04-26
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE filed25-NSE 2025-07-18
AuditorKPMG LLP, New York, New York, United StatesPCAOB Form AP 2026-04-30
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$0-$691K-$422K$1.5MNo debt tagsNeeds four quarters10-Q 2026-11-06
Q2 2026
2026-06-30
$0-$690K-$475K$1.9MNo debt tagsNeeds four quarters10-Q 2026-08-07
Q1 2026
2026-03-31
Not filed-$695K-$438K$2.4MNo debt tagsNeeds four quarters10-Q 2026-05-08
Q4 2025
2025-12-31
$0-$709K-$854K$2.9MNo debt tags$1.4M10-K 2026-03-30
Q3 2025
2025-09-30
$0-$683K$383K$3.7MNo debt tagsNeeds four quarters10-Q 2026-11-06
Q2 2025
2025-06-30
$1.4M$335K-$176K$3.3MNo debt tagsNeeds four quarters10-Q 2026-08-07
Q1 2025
2025-03-31
Not filed-$1.9M-$1.2M$3.5MNo debt tagsNeeds four quarters10-Q 2026-05-08
Q4 2024
2024-12-31
$0-$1.5M-$764K$2.6MNo debt tags$010-K 2026-03-30

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentPOS AM2025-12-15
Latest annual report10-K2026-03-30
Latest quarterly / interim10-Q2026-11-06
Latest current report8-K2026-02-23
Latest proxyDEF 14A2025-12-05

Source: SEC EDGAR submissions feed, 424 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier